Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clotrimazole vs Salicylic Acid in Otomycosis
NCT07535424Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of clotrimazole in otomycosis (2 arms), sponsored by Mayo Clinic. Primary endpoint: Resolution of ear blockage at 2 weeks. Started Nov 2024; status: completed.
02
Drugs
clotrimazole
03
Conditions
otomycosis
Beyond the preview
Go deeper on NCT07535424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07535424.